{"pmid":32472745,"title":"SARS-CoV-2 and human milk: What is the evidence?","text":["SARS-CoV-2 and human milk: What is the evidence?","The novel coronavirus SARS-CoV-2 has emerged as one of the most compelling and concerning public health challenges of our time. To address the myriad issues generated by this pandemic, an interdisciplinary breadth of research, clinical and public health communities has rapidly engaged to collectively find answers and solutions. One area of active inquiry is understanding the mode(s) of SARS-CoV-2 transmission. Although respiratory droplets are a known mechanism of transmission, other mechanisms are likely. Of particular importance to global health is the possibility of vertical transmission from infected mothers to infants through breastfeeding or consumption of human milk. However, there is limited published literature related to vertical transmission of any human coronaviruses (including SARS-CoV-2) via human milk and/or breastfeeding. Results of the literature search reported here (finalized on 17 April 2020) revealed a single study providing some evidence of vertical transmission of human coronavirus 229E; a single study evaluating presence of SARS-CoV in human milk (it was negative); and no published data on MERS-CoV and human milk. We identified 13 studies reporting human milk tested for SARS-CoV-2; one study (a non-peer-reviewed preprint) detected the virus in one milk sample, and another study detected SARS-CoV-2 specific IgG in milk. Importantly, none of the studies on coronaviruses and human milk report validation of their collection and analytical methods for use in human milk. These reports are evaluated here, and their implications related to the possibility of vertical transmission of coronaviruses (in particular, SARS-CoV-2) during breastfeeding are discussed.","Matern Child Nutr","Lackey, Kimberly A","Pace, Ryan M","Williams, Janet E","Bode, Lars","Donovan, Sharon M","Jarvinen, Kirsi M","Seppo, Antti E","Raiten, Daniel J","Meehan, Courtney L","McGuire, Mark A","McGuire, Michelle K","32472745"],"abstract":["The novel coronavirus SARS-CoV-2 has emerged as one of the most compelling and concerning public health challenges of our time. To address the myriad issues generated by this pandemic, an interdisciplinary breadth of research, clinical and public health communities has rapidly engaged to collectively find answers and solutions. One area of active inquiry is understanding the mode(s) of SARS-CoV-2 transmission. Although respiratory droplets are a known mechanism of transmission, other mechanisms are likely. Of particular importance to global health is the possibility of vertical transmission from infected mothers to infants through breastfeeding or consumption of human milk. However, there is limited published literature related to vertical transmission of any human coronaviruses (including SARS-CoV-2) via human milk and/or breastfeeding. Results of the literature search reported here (finalized on 17 April 2020) revealed a single study providing some evidence of vertical transmission of human coronavirus 229E; a single study evaluating presence of SARS-CoV in human milk (it was negative); and no published data on MERS-CoV and human milk. We identified 13 studies reporting human milk tested for SARS-CoV-2; one study (a non-peer-reviewed preprint) detected the virus in one milk sample, and another study detected SARS-CoV-2 specific IgG in milk. Importantly, none of the studies on coronaviruses and human milk report validation of their collection and analytical methods for use in human milk. These reports are evaluated here, and their implications related to the possibility of vertical transmission of coronaviruses (in particular, SARS-CoV-2) during breastfeeding are discussed."],"journal":"Matern Child Nutr","authors":["Lackey, Kimberly A","Pace, Ryan M","Williams, Janet E","Bode, Lars","Donovan, Sharon M","Jarvinen, Kirsi M","Seppo, Antti E","Raiten, Daniel J","Meehan, Courtney L","McGuire, Mark A","McGuire, Michelle K"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32472745","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/mcn.13032","keywords":["covid-19","sars-cov-2","breast milk","breastfeeding","coronavirus","human milk","infectious disease"],"topics":["Transmission"],"weight":1,"_version_":1668255193439928321,"score":9.490897,"similar":[{"pmid":32243068,"title":"Breastfeeding and coronavirus disease-2019: Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies.","text":["Breastfeeding and coronavirus disease-2019: Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies.","The recent COVID-19 pandemic has spread to Italy with heavy consequences on public health and economics. Besides the possible consequences of COVID-19 infection on a pregnant woman and the fetus, a major concern is related to the potential effect on neonatal outcome, the appropriate management of the mother-newborn dyad, and finally the compatibility of maternal COVID-19 infection with breastfeeding. The Italian Society on Neonatology (SIN) after reviewing the limited scientific knowledge on the compatibility of breastfeeding in the COVID-19 mother and the available statements from Health Care Organizations has issued the following indications that have been endorsed by the Union of European Neonatal & Perinatal Societies (UENPS). If a mother previously identified as COVID-19 positive or under investigation for COVID-19 is asymptomatic or paucisymptomatic at delivery, rooming-in is feasible, and direct breastfeeding is advisable, under strict measures of infection control. On the contrary, when a mother with COVID-19 is too sick to care for the newborn, the neonate will be managed separately and fed fresh expressed breast milk, with no need to pasteurize it, as human milk is not believed to be a vehicle of COVID-19. We recognize that this guidance might be subject to change in the future when further knowledge will be acquired about the COVID-19 pandemic, the perinatal transmission of SARS-CoV-2, and clinical characteristics of cases of neonatal COVID-19.","Matern Child Nutr","Davanzo, Riccardo","Moro, Guido","Sandri, Fabrizio","Agosti, Massimo","Moretti, Corrado","Mosca, Fabio","32243068"],"abstract":["The recent COVID-19 pandemic has spread to Italy with heavy consequences on public health and economics. Besides the possible consequences of COVID-19 infection on a pregnant woman and the fetus, a major concern is related to the potential effect on neonatal outcome, the appropriate management of the mother-newborn dyad, and finally the compatibility of maternal COVID-19 infection with breastfeeding. The Italian Society on Neonatology (SIN) after reviewing the limited scientific knowledge on the compatibility of breastfeeding in the COVID-19 mother and the available statements from Health Care Organizations has issued the following indications that have been endorsed by the Union of European Neonatal & Perinatal Societies (UENPS). If a mother previously identified as COVID-19 positive or under investigation for COVID-19 is asymptomatic or paucisymptomatic at delivery, rooming-in is feasible, and direct breastfeeding is advisable, under strict measures of infection control. On the contrary, when a mother with COVID-19 is too sick to care for the newborn, the neonate will be managed separately and fed fresh expressed breast milk, with no need to pasteurize it, as human milk is not believed to be a vehicle of COVID-19. We recognize that this guidance might be subject to change in the future when further knowledge will be acquired about the COVID-19 pandemic, the perinatal transmission of SARS-CoV-2, and clinical characteristics of cases of neonatal COVID-19."],"journal":"Matern Child Nutr","authors":["Davanzo, Riccardo","Moro, Guido","Sandri, Fabrizio","Agosti, Massimo","Moretti, Corrado","Mosca, Fabio"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243068","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1111/mcn.13010","keywords":["birth","breastfeeding","breastfeeding promotion","human milk","infectious disease","neonate"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666138492115091456,"score":395.57162},{"pmid":32472683,"title":"Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).","text":["Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).","SARS-CoV-2 is a novel coronavirus and causative pathogen to the pandemic illness COVID-19. Although RNA has been detected in various clinical samples, no reports to date have documented SARS-CoV-2 in human milk. This case report describes an actively breastfeeding patient with COVID-19 infection with detectable viral RNA in human milk.","Clin Infect Dis","Tam, Patrick C K","Ly, Kathleen M","Kernich, Max L","Spurrier, Nicola","Lawrence, Diana","Gordon, David L","Tucker, Emily C","32472683"],"abstract":["SARS-CoV-2 is a novel coronavirus and causative pathogen to the pandemic illness COVID-19. Although RNA has been detected in various clinical samples, no reports to date have documented SARS-CoV-2 in human milk. This case report describes an actively breastfeeding patient with COVID-19 infection with detectable viral RNA in human milk."],"journal":"Clin Infect Dis","authors":["Tam, Patrick C K","Ly, Kathleen M","Kernich, Max L","Spurrier, Nicola","Lawrence, Diana","Gordon, David L","Tucker, Emily C"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32472683","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/cid/ciaa673","keywords":["covid-19","human milk","sars-cov-2","breastfeeding"],"topics":["Case Report"],"weight":1,"_version_":1668255193331924992,"score":352.5105},{"pmid":32479766,"title":"Breastfeeding during the COVID-19 pandemic: suggestions on behalf of Woman Study Group of AMD.","text":["Breastfeeding during the COVID-19 pandemic: suggestions on behalf of Woman Study Group of AMD.","SARS-Cov2 infection has recently spread to Italy with important consequences on pregnancy management, mother and child health and mother-child contact. Breastfeeding improves the health of mother and child and reduces risk of neonatal infection with other pathogens that are likely to cause serious illness. To date no evidence confirmed COVID-19 vertical transmission from infected pregnant mother to their fetus. However it is well known that an infected mother can transmit the COVID-19 virus through respiratory droplets during breastfeeding or intimate contact. Thus, the mothers with known or suspected COVID-19 should adhere to standard and contact precautions during breastfeeding. Woman Study Group of AMD, after reviewing current knowledge about COVID-19 vertical transmission and the compatibility of breastfeeding in COVID-19 mother, the available recommendations from Health Care Organizations and main experts opinions, issued the following suggestions on breastfeeding during the COVID-19 pandemic, addressed both to mothers with and without diabetes It should be considered that following suggestions may change in the future when more evidence is acquired regarding SARS-Cov2 infection.","Diabetes Res Clin Pract","Giuliani, C","Li Volsi, P","Brun, E","Chiambretti, A","Giandalia, A","Tonutti, L","Di Bartolo, P","Napoli, A","32479766"],"abstract":["SARS-Cov2 infection has recently spread to Italy with important consequences on pregnancy management, mother and child health and mother-child contact. Breastfeeding improves the health of mother and child and reduces risk of neonatal infection with other pathogens that are likely to cause serious illness. To date no evidence confirmed COVID-19 vertical transmission from infected pregnant mother to their fetus. However it is well known that an infected mother can transmit the COVID-19 virus through respiratory droplets during breastfeeding or intimate contact. Thus, the mothers with known or suspected COVID-19 should adhere to standard and contact precautions during breastfeeding. Woman Study Group of AMD, after reviewing current knowledge about COVID-19 vertical transmission and the compatibility of breastfeeding in COVID-19 mother, the available recommendations from Health Care Organizations and main experts opinions, issued the following suggestions on breastfeeding during the COVID-19 pandemic, addressed both to mothers with and without diabetes It should be considered that following suggestions may change in the future when more evidence is acquired regarding SARS-Cov2 infection."],"journal":"Diabetes Res Clin Pract","authors":["Giuliani, C","Li Volsi, P","Brun, E","Chiambretti, A","Giandalia, A","Tonutti, L","Di Bartolo, P","Napoli, A"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479766","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.diabres.2020.108239","keywords":["covid-19","breastfeeding","diabetes","pregnancy"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention","Transmission"],"weight":1,"_version_":1668437834973839360,"score":307.0819},{"pmid":32454807,"pmcid":"PMC7241573","title":"COVID-19 and newborn health: systematic review.","text":["COVID-19 and newborn health: systematic review.","Objective: To describe perinatal and neonatal outcomes in newborns exposed to SARS-CoV-2. Methods: A systematic review was conducted by searching PubMed Central, LILACS, and Google Scholar using the keywords 'covid ' AND 'newborn' OR 'child' OR 'infant,' on 18 March 2020, and again on 17 April 2020. One researcher conducted the search and extracted data on demographics, maternal outcomes, diagnostic tests, imaging, and neonatal outcomes. Results: Of 256 publications identified, 20 met inclusion criteria and comprised neonatal outcome data for 222 newborns whose mothers were suspected or confirmed to be SARS-CoV-2 positive perinatally (17 studies) or of newborns referred to hospital with infection/pneumonia (3 studies). Most (12 studies) were case-series reports; all were from China, except three (Australia, Iran, and Spain). Of the 222 newborns, 13 were reported as positive for SARS-CoV-2; most of the studies reported no or mild symptoms and no adverse perinatal outcomes. Two papers among those from newborns who tested positive reported moderate or severe clinical characteristics. Five studies using data on umbilical cord blood, placenta, and/or amniotic fluid reported no positive results. Nine studies reported radiographic imaging, including 5 with images of pneumonia, increased lung marking, thickened texture, or high-density nodular shadow. Minor, non-specific changes in biochemical variables were reported. Studies that tested breast milk reported negative SARS-CoV-2 results. Conclusions: Given the paucity of studies at this time, vertical transmission cannot be confirmed or denied. Current literature does not support abstaining from breastfeeding nor separating mothers and newborns. Further evidence and data collection networks, particularly in the Americas, are needed for establishing definitive guidelines and recommendations.","Rev Panam Salud Publica","Duran, Pablo","Berman, Stephen","Niermeyer, Susan","Jaenisch, Thomas","Forster, Thais","Gomez Ponce de Leon, Rodolfo","De Mucio, Bremen","Serruya, Suzanne","32454807"],"abstract":["Objective: To describe perinatal and neonatal outcomes in newborns exposed to SARS-CoV-2. Methods: A systematic review was conducted by searching PubMed Central, LILACS, and Google Scholar using the keywords 'covid ' AND 'newborn' OR 'child' OR 'infant,' on 18 March 2020, and again on 17 April 2020. One researcher conducted the search and extracted data on demographics, maternal outcomes, diagnostic tests, imaging, and neonatal outcomes. Results: Of 256 publications identified, 20 met inclusion criteria and comprised neonatal outcome data for 222 newborns whose mothers were suspected or confirmed to be SARS-CoV-2 positive perinatally (17 studies) or of newborns referred to hospital with infection/pneumonia (3 studies). Most (12 studies) were case-series reports; all were from China, except three (Australia, Iran, and Spain). Of the 222 newborns, 13 were reported as positive for SARS-CoV-2; most of the studies reported no or mild symptoms and no adverse perinatal outcomes. Two papers among those from newborns who tested positive reported moderate or severe clinical characteristics. Five studies using data on umbilical cord blood, placenta, and/or amniotic fluid reported no positive results. Nine studies reported radiographic imaging, including 5 with images of pneumonia, increased lung marking, thickened texture, or high-density nodular shadow. Minor, non-specific changes in biochemical variables were reported. Studies that tested breast milk reported negative SARS-CoV-2 results. Conclusions: Given the paucity of studies at this time, vertical transmission cannot be confirmed or denied. Current literature does not support abstaining from breastfeeding nor separating mothers and newborns. Further evidence and data collection networks, particularly in the Americas, are needed for establishing definitive guidelines and recommendations."],"journal":"Rev Panam Salud Publica","authors":["Duran, Pablo","Berman, Stephen","Niermeyer, Susan","Jaenisch, Thomas","Forster, Thais","Gomez Ponce de Leon, Rodolfo","De Mucio, Bremen","Serruya, Suzanne"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454807","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.26633/RPSP.2020.54","keywords":["coronavirus infection","sars virus","congenital, hereditary, and neonatal diseases and abnormalities","infectious disease transmission, vertical","pandemics","virus diseases"],"locations":["China","Australia","Iran","Spain","placenta"],"countries":["China","Iran, Islamic Republic of","Spain","Australia"],"countries_codes":["CHN|China","IRN|Iran, Islamic Republic of","ESP|Spain","AUS|Australia"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1667881798407815168,"score":266.44257},{"pmid":32454808,"pmcid":"PMC7241574","title":"To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19.","text":["To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19.","A rapid systematic review was carried out to evaluate the current evidence related to the presence of SARS-CoV-2 in breast milk from pregnant women with COVID-19. Eight studies analyzing the presence of SARS-CoV-2 RNA in the breast milk of 24 pregnant women with COVID-19 during the third trimester of pregnancy were found. All patients had fever and/or symptoms of acute respiratory illness and chest computed tomography images indicative of COVID-19 pneumonia. Most pregnant women had cesarean delivery (91.7%) and two neonates had low birthweight (< 2 500 g). Biological samples collected immediately after birth from upper respiratory tract (throat or nasopharyngeal) of neonates and placental tissues showed negative results for the presence SARS-CoV-2 by RT-PCR test. No breast milk samples were positive for SARS-CoV-2 and, to date, there is no evidence on the presence of SARS-CoV-2 in breast milk of pregnant women with COVID-19. However, data are still limited and breastfeeding of women with COVID-19 remains a controversial issue. There are no restrictions on the use of milk from a human breast milk bank.","Rev Panam Salud Publica","Martins-Filho, Paulo Ricardo","Santos, Victor Santana","Santos, Hudson P Jr","32454808"],"abstract":["A rapid systematic review was carried out to evaluate the current evidence related to the presence of SARS-CoV-2 in breast milk from pregnant women with COVID-19. Eight studies analyzing the presence of SARS-CoV-2 RNA in the breast milk of 24 pregnant women with COVID-19 during the third trimester of pregnancy were found. All patients had fever and/or symptoms of acute respiratory illness and chest computed tomography images indicative of COVID-19 pneumonia. Most pregnant women had cesarean delivery (91.7%) and two neonates had low birthweight (< 2 500 g). Biological samples collected immediately after birth from upper respiratory tract (throat or nasopharyngeal) of neonates and placental tissues showed negative results for the presence SARS-CoV-2 by RT-PCR test. No breast milk samples were positive for SARS-CoV-2 and, to date, there is no evidence on the presence of SARS-CoV-2 in breast milk of pregnant women with COVID-19. However, data are still limited and breastfeeding of women with COVID-19 remains a controversial issue. There are no restrictions on the use of milk from a human breast milk bank."],"journal":"Rev Panam Salud Publica","authors":["Martins-Filho, Paulo Ricardo","Santos, Victor Santana","Santos, Hudson P Jr"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454808","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.26633/RPSP.2020.59","keywords":["coronavirus infection","sars virus","breast feeding","pandemics","pneumonia, viral","virus diseases"],"topics":["Diagnosis"],"weight":1,"_version_":1667983494513426432,"score":265.49326}]}